Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent
1977-01-24
1978-01-03
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Reduced antigenicity, reduced ability to bind complement, or...
2601125TR, A61K 3700, C07C10352
Patent
active
040667499
ABSTRACT:
A novel tetrapeptide L-2-ketopiperidine-6-carbonyl-L-histidyl-L-thiazolidine-4-carbonyl-.beta.- alanin-amide, (L-Kpc-L-His-L-Tca-.beta.-ala-NH.sub.2), is a stimulant of the central nervous system. It is preparable by standard peptide synthetic procedures.
REFERENCES:
patent: 3959248 (1976-05-01), Veber et al.
Willson, et al.; Biopolymers, 15, 2317 1976.
Hirschmann Ralph F.
Nutt Ruth F.
Veber Daniel F.
Merck & Co. , Inc.
Nicholson William H.
Phillips Delbert R.
Westlake, Jr. Harry E.
LandOfFree
Tetrapeptide analog of TRH does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetrapeptide analog of TRH, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrapeptide analog of TRH will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-281450